evipedia.ai
← Back

OPCs for Health & Longevity

Created on 11/07/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

OPCs are plant compounds sold mainly as grape seed and pine bark extract supplements for blood vessel health. Trials show small drops in blood pressure, eased leg vein symptoms and slightly better blood fats, only while taken; many are small and maker-funded. Clearing worn-out cells remains a mouse-only idea. Side effects are generally mild stomach complaints; adding high-dose vitamin C raised blood pressure in people on blood pressure treatment. (Full Review)

Protocol

Grape seed extract
300 mg/day
400 mg/day in one blood pressure trial; several trials split it into 150 mg twice daily
Pine bark extract (Pycnogenol)
100–200 mg/day
150 mg/day for osteoarthritis; trials gave doses with meals
Cranberry proanthocyanidins
At least 36 mg PACs daily
For urinary infection prevention
Time to effect
Blood pressure
6–12 weeks
Returned to baseline four weeks after stopping grape seed extract
Venous symptoms
Within 12 weeks
Leg heaviness and swelling
Urinary infection prevention
12–24 weeks
Length of the cranberry trials

Benefits

Contraindications
  • People with peanut allergy using unverified grape seed products
  • People with treated hypertension taking vitamin C at 500 mg/day or more (Avoid the combination)
  • Pregnancy and breastfeeding
  • The two weeks before scheduled surgery
  • Known allergy to grapes, pine or cranberries
    •
Key Interactions
  • ACE inhibitors (enalapril, lisinopril, ramipril): additive blood pressure lowering
  • Glucose-lowering drugs (metformin, sulfonylureas): possible low blood sugar
  • Warfarin with cranberry products: bleeding
    •
Theoretical (inferred from mechanism)
  • Anticoagulants and antiplatelet drugs with grape seed or pine bark extracts (warfarin, apixaban, clopidogrel, aspirin): increased bleeding or bruising
  • NSAIDs (such as ibuprofen, naproxen): greater gastrointestinal bleeding risk
  • Antiplatelet supplements (fish oil, ginkgo, garlic, vitamin E): increased bleeding risk
  • Blood pressure-lowering supplements (beetroot nitrate, coenzyme Q10, magnesium): dizziness or low blood pressure
  • Glucose-lowering supplements (berberine, chromium, cinnamon): low blood sugar in people on diabetes drugs
  • CYP3A4 substrates with grape seed extract (simvastatin, cyclosporine, midazolam): higher drug levels
  • Immunosuppressants (tacrolimus, cyclosporine): altered immunosuppression
    •

Risk & Side Effects

  • High:
  • Medium: Blood pressure rise with vitamin C
    •
  • Low: Gastrointestinal upset and headache; rhabdomyolysis with excess pine bark extract
    •
  • Speculative: Bleeding tendency; reduced iron absorption; peanut allergen exposure from adulterated products; liver injury from polymeric fractions
    •

Monitoring

Marker Target Why
Home blood pressure Below 120/80 mmHg Expected to change; safety check with antihypertensives
LDL cholesterol Below 100 mg/dL Expected to change
Triglycerides Below 150 mg/dL Expected to change
HbA1c 4.0–5.6% Expected to change in prediabetes or diabetes; safety check with glucose-lowering drugs
Fasting glucose 70–99 mg/dL Expected to change; safety check for low blood sugar with diabetes drugs
INR (warfarin users only) No established target for OPC use; track deviation from own stable therapeutic INR Safety check: a change alters bleeding risk

Cadence: Home blood pressure twice weekly for the first four weeks, then monthly; INR at one to two weeks after starting for warfarin users; fasting glucose, HbA1c and lipids at 12 weeks, then every 6–12 months

Qualitative Assessment

  • Leg heaviness, ankle swelling and visible vein symptoms
  • Joint pain and morning stiffness
  • Skin texture and age-spot appearance
  • Gastrointestinal comfort after doses
  • Unusual bruising or bleeding from gums or minor cuts
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.